Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines
Introduction: Regulatory agencies are responsible for defining the use of off-label (OL) and unlicensed (UL) drug prescription in neonatal intensive care. However, these regulatory criteria may differ between agencies in different countries. The aim of this study was to establish the frequency of OL...
Saved in:
Main Authors: | Haline Tereza Matias Lima Costa (Author), Arlan Peres Florencio (Author), Priscilla Karilline do Vale Bezerra (Author), Jéssica Escorel Chaves Cavalcanti (Author), Tatiana Xavier Costa (Author), Flavia Evelyn Medeiros Fernandes (Author), Martins Rand Randall (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluación comparativa de la prescripción off-label y unlicensed de fármacos en cuidados intensivos neonatales: Guías de la FDA versus guías brasileñas
by: Haline Tereza Matias Lima Costa, et al.
Published: (2021) -
Off-label and unlicensed drugs in neonatology
by: Segundo Rite-Gracia, et al.
Published: (2021) -
Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
by: Laura Goedel dos Santos, et al.
Published: (2023) -
Unlicensed and off-label drug use in paediatric wards
by: Suhair Moayid Rasheed
Published: (2010) -
EXTENT OF UNLICENSED AND OFF-LABEL DRUG USE IN THE PEDIATRIC PRACTICE OF SMOLENSK
by: S.A. Rachina, et al.
Published: (2010)